iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding iSpecimen Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 473.1K | 475.6K | +2.48K (+0.5%) |
| Value | $781.0K | $653.0K | −$128.0K (−16.4%) |
New holders (1)
Institutions that held iSpecimen Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Claro Advisors LLC | 17,305 | $23.8K | 0.01% |
Sold out (3)
Institutions that held iSpecimen Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Virtu Financial LLC | 10,676 | $18.0K |
| UBS Group AG | 5,278 | $9.00K |
| GHP Investment Advisors, Inc. | 37 | $0 |